LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2020 Results - Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (LGND) Q4 2020 Earnings Conference Call February 3, 2021 8:30 AM ET Company Participants Patrick O'Brien - Investor Relations John Higgins - Chief Executive Officer Matt Korenberg - Executive Vice President, Finance and Chief Financial Officer Matt Foehr - President and Chief Operating Officer Conference Call Participants Joe Pantginis - H.C. Wainwright Balaji Prasad - Barclays Matt Hewitt - Craig-Hallum Capital Group Scott Henry - Roth Capital Dana Flanders - Guggenheim Securities Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Ligand Pharmaceuticals’ Q4 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Patrick O'Brien. Thank you. Please go ahead. Patrick O'Brien Thank you, Brandy, and welcome to Ligand's fourth quarter

For further details see:

Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2020 Results - Earnings Call Transcript